MAIN $39.60 -0.8016%
PEI $2.39 75.7353%
MGGT.L $798.80 0%
BOD.L $0.95 0%
1101.HK $0.05 -5.6604%
HCMA $10.59 0%
0256.HK $1.12 -0.885%
OSW $11.76 -0.8853%
CUT $29.54 -0.8227%
TWND $9.80 0%
TPGY $10.04 0%
HDT.L $72.75 -4.2763%
JPEM $51.25 -0.8952%
2191.HK $2.87 -1.0345%
0194.HK $6.31 0%
0P0000KSPB.L $59 716.50 0.4413%
COUR.PA $128.00 0%
CSOD $57.49 0%
NWL $9.27 -2.421%
CDC $58.20 -0.4447%
RDOR3.SA $24.93 -1.1499%
ICAP $22.56 0.2662%
TDSA $20.89 -0.3815%
UNAM $1.10 0.0091%
SIJ $15.49 0.2096%
XGDD.L $29.02 0.1553%
MEG $35.06 -2.1763%
QLS $25.09 0%
WEBS $21.11 4.4016%
VIR $24.41 0.6598%
SEUR.L $67.35 0.2605%
BSBK $8.12 -1.4563%
TWNK $26.32 -0.5856%
OIG $2.20 -2.8761%
GPK $25.69 0.0214%
DISW.L $555.32 0%
EUA.L $2.88 4.5455%
0264.HK $0.77 0%
8143.HK $0.04 13.1579%
NEW $1.36 0%
GBTG $6.11 0.1639%
0QQZ.L $482.00 -1.1282%
1711.HK $0.18 0%
LPTX $0.43 0.7765%
0UU0.L $7.99 -8.0552%
VCLT $78.17 -0.7617%
INO $0.71 -9.7934%
MIGO.L $324.00 0.6211%
NMZ $10.46 0.2926%
HSW.L $142.50 -2.3973%
82822.HK $11.88 -1.3289%
1826.HK $0.10 0%
AMPY $6.68 0%
ESC.L $31.00 0%
0499.HK $0.17 0%
CVY $20.45 -0.7763%
0554.HK $0.23 1.7699%
8479.HK $0.72 16.129%
CHAU $19.93 -4.2292%
0LNT.L $13.92 0.266%
FTEV $10.18 0%
AGAP.L $526.38 0.5972%
PXH $18.39 -1.4129%
IDEA.L $349.00 0%
0382.HK $2.70 -4.5936%
CLRM $10.07 0%
IVAN $7.68 0%
BIDI3.SA $3.40 0%
USB-PQ $15.51 -0.4814%
LSVX $15.35 0%
OIBR-C $0.81 0%
VTWO $69.35 -0.7725%
BKU $15.94 -3.4525%
AGC $11.01 0%
ADNWW $0.09 -9.9%
CO $2.99 0%
LFMDP $15.70 -0.2985%
MOAT.L $47.87 -0.0104%
GSQ.CN $0.18 0%
DPH.L $3 738.00 -0.4262%
0131.HK $2.10 0%
PSAGU $10.06 0%
ROP $459.53 0.2323%
JE $1.75 0%
SBLKZ $25.39 0%
TAIT $3.61 0.5014%
2722.HK $0.66 -2.9412%
GSAQU $9.99 0%
LLAP $1.86 0.8152%
LCUT $4.79 -2.8398%
TLGYW $0.06 31.3333%
8462.HK $0.05 0%
AVNW $29.46 -0.408%
ALREW.PA $5.14 -0.7722%
VXUS $55.64 -0.6873%
VNAM $15.79 1.0566%
1703.HK $0.50 -1%
ETDD.PA $13.02 0.339%
MLSTR.PA $7.60 0%
TMBR $1.56 -2.5%
Eng
Логотип
Eng
Лого

Hua Medicine (Shanghai) Ltd. 2552.HK

$2.76

+$0.02 (0.73%)
На 18:03, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    2706609623.00000000

  • week52high

    5.02

  • week52low

    1.85

  • Revenue

    17599000

  • P/E TTM

    -8

  • Beta

    1.36228200

  • EPS

    -0.31000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    30 мар 2023 г. в 02:15

Описание компании

Hua Medicine (Shanghai) Ltd. operates as a clinical-stage drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin that is in Phase I clinical trial for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone for NASH; in combination with GLP-1 for Alzheimer diseases; and in combination with late stage T2D and Type 1 Diabetes. In addition, it is developing mGLUR5 for the treatment of Parkinson's disease levodopa-induced dyskinesia. The company was incorporated in 2011 and is based in Beijing, China.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек